Demo: Global Plan Dashboard

Home About Platform Case Study Features App Home Launch Demo Global Plan Demo Global Plan Implementation Training Contact

Home Launch Dashboard Global Plan Dashboard Global Plan Resource Centre

Global Dashboard

Launch Date: 10 Aug 28

Xeljanz 2L NSCLC

Status Timeline Meeting Report

Shape the Product

Regulatory Submission

Target Profile & Patient Journey

Evidence Generation

Product Differentiation

Brand Strategy & Campaign

Lifecycle Management (LCM)

Manufacturing & Supply

Shape the Market

Disease State & Landscape

Segmentation

Competitive Landscape

Unmet Needs

Value Proposition

Patient Advocacy

KOL Strategy & Engagement

Early Access Programmes

Market Access & Pricing Strategy

HTA & Reimbursement

Publications Strategy & Plan

HCP Education & Congresses

PR & Media Engagement

Launch Activation & Sequencing

Shape the Organization

Organisational Build & Recruitment

Salesforce Size & Structure

Training & Education Programme

Performance Management & KPIs

Financial Forecast

Plan status

63%

58 Completed

32 Not Started

1 In Progress

0 Due in next 30 days

8 Overdue

Global Dashboard — Status Report

Xeljanz 2L NSCLC · Generated 27 Feb 2026

Achievements since last meeting

Target Profile & Patient Journey — Final version approved by Global Medical team. 18 Feb 26

Romania Launch — Product successfully launched. First prescriptions recorded. 6 Feb 26

Denmark — Reimbursement decision received. All milestones complete. 2 Jan 26

Work in Progress

Market Access & Pricing Strategy — Global framework being finalised; country adaptations underway.

HTA & Reimbursement — UK & France — HTA submissions in preparation; evidence packages under review.

Training & Education Programme — Medical Science Liaisons onboarding complete; commercial training in progress.

Risks & Issues

Evidence Generation — 2 tasks overdue. Clinical data submission delayed by 3 weeks. HIGH

England — HTA — NICE submission timeline at risk due to resource constraints. HIGH

Patient Advocacy — 8 tasks behind schedule. Patient group engagement requires additional resources. MEDIUM

Plan status summary

63%

58Completed

32Not Started

1In Progress

0Due in 30 days

8Overdue

Click Status / Timeline / Meeting Report tabs to switch views. n red = tasks at risk · ! amber = at risk · ✓ = complete

Explore more demos or get in touch with our team.

Launch Dashboard Demo All Features Contact André Moa